Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Quinolones Market Revenue Outlook: What CAGR Lies Ahead Through 2030?
The quinolones market has experienced steady expansion in recent years. It is projected to expand from $51.89 billion in 2025 to $54.48 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.0%. The historical growth of this market can be ascribed to several factors, including the increasing prevalence of bacterial infections, a rise in hospital admissions, a strong demand for broad-spectrum antibiotics, the proliferation of retail pharmacies, and governmental efforts to control infectious diseases.
The quinolones market is projected to experience substantial expansion over the upcoming years. It is anticipated to reach $66.44 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. This projected growth during the forecast period stems from factors such as progress in precision medicine, the creation of innovative quinolone formulations, wider reach of online pharmacy channels, heightened understanding of antimicrobial stewardship, and the increasing uptake of digital health monitoring instruments. Key developments expected during this period involve improved management of antibiotic resistance, broader access to generic drugs, customized treatment methodologies, an increase in outpatient and home healthcare provisions, and greater investment in research and development for new quinolones.
Get A Free Sample Report With In-Depth Market Insights:
Quinolones Market Growth Factors: What’s Supporting Expansion?
The escalating risk of antimicrobial resistance is projected to fuel the expansion of the quinolones market moving forward. Antimicrobial resistance (AMR) signifies the capability of microorganisms, including bacteria, viruses, parasites, and fungi, to withstand the effects of antimicrobial drugs. Quinolones possess a broad spectrum of activity, rendering them effective against various types of bacteria. These medications, prescribed for specific infections, can penetrate diverse tissues, making them a preferred option when choices are limited. For instance, in October 2025, according to the World Health Organization, a US-based intergovernmental organization, a comprehensive global assessment examined antibiotic resistance prevalence and trends. This analysis utilized data from over 23 million confirmed cases of bloodstream, urinary tract, and gastrointestinal infections, as well as urogenital gonorrhea. These findings were based on reports provided by 104 countries in 2023. Thus, the increasing danger of antimicrobial resistance is driving the growth of the quinolones market.
Quinolones Market Segment Trends And Revenue Contributors
The quinolones market covered in this report is segmented –
1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types
2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen
3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Quinolones Market Industry Trends: What’s Reshaping Demand?
Leading companies in the quinolones market are prioritizing innovative products, such as fluoroquinolone antibiotic eye drops, to boost their market revenues. These eye drops represent a category of antibiotics employed in treating bacterial infections of the eye. For example, in July 2023, Harrow Health Inc., a US-based pharmaceutical firm, introduced Vigamox. This solution is isotonic, possessing an osmolality of approximately 290 mOsm/kg, and contains 5.45 mg moxifloxacin hydrochloride, equivalent to 5 mg moxifloxacin base. The medication is provided in a 3-milliliter bottle, delivered as a sterile ophthalmic solution within a dispensing system consisting of a tan polypropylene closure, a dispensing plug, and a natural low-density polyethylene bottle. Vigamox is advised for preventing eye infections both before and after surgical procedures.
Quinolones Market Competitive Landscape: Which Companies Lead The Industry?
Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.
View The Full Quinolones Market Report:
Quinolones Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
